The state of rat kidneys after injection of bone marrow multipotent stromal cells (MSC) labeled with Vybrant CM-Dil into intact or resected liver was studied by fluorescence microscopy. The main structural changes in the kidneys after MSC injection into intact and partially resected liver manifested as granular dystrophy and necrobiotic/necrotic changes in single epithelial cells of the distal tubules and collecting ducts, thrombosis of some vessels, progression of an ascending urinary tract infection (detection of dust-like fluorescent objects), which can be due to the immunomodulating or even immunosuppressive influence of MSC and their detritus. MSC injected into the intact or resected liver, as well as the products of their degradation were not detected in the kidneys at all terms of observation. After injection of MSC into partially resected liver, manifestations of bacterial contamination of the renal medulla appeared later. The injection of MSC into the liver can be complicated by thrombosis of the renal vessels, which should be taken into account when using this administration route in the cell therapy.
Similar content being viewed by others
References
Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824-833. doi: https://doi.org/10.1016/j.stem.2018.05.004
Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell. Mol. Life Sci. 2019;76(17):3323-3348. doi: https://doi.org/10.1007/s00018-019-03125-1
Wang H, Thorling C.A, Xu ZP, Crawford DHG, Liang X, Liu X, Roberts MS. Visualization and modeling of the in vivo distribution of mesenchymal stem cells. Curr. Protoc. Stem Cell Biol. 2017;43:2B.8.1-2B.8.17. doi: https://doi.org/10.1002/cpsc.39
Konieva AA, Kholodenko IV, Shragina OA, Kholodenko RV, Burunova VV, Bibaeva LV, Yarygin KN, Yarygin VN. Functional properties of mesenchymal stem cells labeled with magnetic microparticles in vitro and analysis of their distribution after transplantation. Bull. Exp. Biol. Med. 2010;150(1):131-136. doi: https://doi.org/10.1007/s10517-010-1087-9.
Maiborodin IV, Maslov RV, Mikheeva TV, Khomenyuk SV, Maiborodina VI, Morozov VV, Ryaguzov ME, Marchukov SV, Kozlova JuN. The distribution of multipotent mesenchymal stromal cells and their detritus throughout the organism after subcutaneous introduction. Zh. Obshch. Biol. 2020;81(2):96-107. Russian. doi: https://doi.org/10.31857/S0044459620020050
Tan X, Gong YZ, Wu P, Liao DF, Zheng XL. Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy. Int. J. Mol. Sci. 2014;(8):14 348-14 363. doi: https://doi.org/10.3390/ijms150814348
Maiborodin IV, Maslov RV, Mikheeva TV, Elovskiy AA, Figurenko NF, Maiborodina VI, Shevela AI, Anishchenko VV. Macrophagal adsorption of multipotent mesenchymal stromal cells and their debris from vascular bed proves the migration of these cellular elements through the vessels after tissue injection. Mol. Med. 2018;16(4):56-61. Russian. doi: https://doi.org/10.29296/24999490-2018-04-10
Camp DM, Loeffler DA, Farrah DM, Borneman JN, LeWitt PA. Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson’s disease. J. Neuroinflammation. 2009;6:17. doi: https://doi.org/10.1186/1742-2094-6-17
Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int. J. Mol. Sci. 2022;23(17):10023. doi: https://doi.org/10.3390/ijms231710023
Weiss ARR, Dahlke MH. Immunomodulation by Mesenchymal Stem Cells (MSC): Mechanisms of action of living, apoptotic, and dead MSC. Front. Immunol. 2019;10:1191. doi: https://doi.org/10.3389/fimmu.2019.01191
Maiborodin IV, Figurenko NF, Elovskiy AA, Mikheeva TV, Maslov RV, Maiborodina VI, Shevela AI. Possibility of inflammatory injures development in intact liver after the multipotent stromal cell injection in experiment. Novosti Khirurgii. 2019;27(1):5-15. Russian. doi: https://doi.org/10.18484/2305-0047.2019.1.5
Maiborodin I, Lushnikova E, Klinnikova M, Klochkova S. Some special aspects of liver repair after resection and administration of multipotent stromal cells in experiment. Life (Basel). 2021. 11(1):66. doi: https://doi.org/10.3390/life11010066
Kiselevskii MV, Vlasenko RY, Stepanyan NG, Shubina IZ, Sitdikova SM, Kirgizov KI, Varfolomeeva SR. Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory? Bull. Exp. Biol. Med. 2021;172(2):250-253. doi: https://doi.org/10.1007/s10517-021-05371-5
Moskaleva EY, Semochkina YP, Shuvatova VG, Rodina AV, Krasheninnikova AA. Mesenchymal Stem Cells from Mouse Adipose Tissue Stimulate Tumor Growth. Bull. Exp. Biol. Med. 2019;167(1):145-149. doi: https://doi.org/10.1007/s10517-019-04479-z
Takasaki Y, Watanabe M, Yukawa H, Sabarudin A, Inagaki K, Kaji N, Okamoto Y, Tokeshi M, Miyamoto Y, Noguchi H, Umemura T, Hayashi S, Baba Y, Haraguchi H. Estimation of the distribution of intravenously injected adipose tissue-derived stem cells labeled with quantum dots in mice organs through the determination of their metallic components by ICPMS. Anal. Chem. 2011;83(21):8252-8258. doi: https://doi.org/10.1021/ac202053y
Lei Y, Tang H, Yao L, Yu R, Feng M, Zou B. Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. Bioconjug. Chem. 2008. 19(2):421-427. doi: https://doi.org/10.1021/bc0700685
Baird FJ, Wadsworth MP, Hill JE. Evaluation and optimization of multiple fluorophore analysis of a Pseudomonas aeruginosa biofilm. J. Microbiol. Methods. 2012;90(3):192-196. doi: https://doi.org/10.1016/j.mimet.2012.05.004
Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol. Sci. 2020;41(9):653-664. doi: https://doi.org/10.1016/j.tips.2020.06.009
Kugeratski FG, Kalluri R. Exosomes as mediators of immune regulation and immunotherapy in cancer. FEBS J. 2021;288(1):10-35. doi: https://doi.org/10.1111/febs.15558
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 27-33, March, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maiborodin, I.V., Maslov, R.V., Marchukov, S.V. et al. Possible Kidney Complications after Application of Cell Technologies for the Repair of the Resected Liver. Bull Exp Biol Med 175, 138–143 (2023). https://doi.org/10.1007/s10517-023-05825-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05825-y